BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 21061800)

  • 1. Comparative findings of oncogenic cervical risk and its follow-up in two different periods 1982-1999 and 2000-2007.
    Garrido MJ
    Eur J Gynaecol Oncol; 2010; 31(5):559-61. PubMed ID: 21061800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACOG Practice Bulletin No. 99: management of abnormal cervical cytology and histology.
    Obstet Gynecol; 2008 Dec; 112(6):1419-1444. PubMed ID: 19037054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The degree of agreement between HPV testing, pap smear and colposcopy in cervical dysplasia diagnosis.
    Melinte-Popescu A; Costăchescu G
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):536-9. PubMed ID: 23077949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical dysplasias 1982-2010 in the Republic of Panama. Diagnosis, treatment, and evolution.
    Garrido JL
    Eur J Gynaecol Oncol; 2014; 35(1):56-8. PubMed ID: 24654463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Human papillomavirus typing in routine cervical smears. Results from a series of 3778 patients].
    Levert M; Clavel C; Graesslin O; Masure M; Birembaut P; Quereux C; Gabriel R
    Gynecol Obstet Fertil; 2000 Oct; 28(10):722-8. PubMed ID: 11244634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of HPV testing in the follow-up of women treated for cervical dysplasia.
    Ribaldone R; Boldorini R; Capuano A; Arrigoni S; Di Oto A; Surico N
    Arch Gynecol Obstet; 2010 Aug; 282(2):193-7. PubMed ID: 20012636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of cervical dysplasia among human papillomavirus-infected women in Korea: a multicenter prospective study.
    Park Y; Kim TJ; Hwang CS; Cho CH; Jeong DH; Seong SJ; Lee JK; Hur S; Kee MK; Seong J; Ki M
    J Gynecol Oncol; 2019 May; 30(3):e50. PubMed ID: 30887765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immediate risk of HSIL presence in women who have both ASC-US cytology and negative high-risk HPV test.
    Ozturk M; Umudum H; Aydin A; Ulubay M; Keskin U; Dede M; Yenen MC
    Eur J Gynaecol Oncol; 2016; 37(2):232-7. PubMed ID: 27172751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twenty years of contributions to the study and prevention of uterine cancer.
    Garrido Martínez JL; Díaz MM; Villarreal A
    Eur J Gynaecol Oncol; 2006; 27(6):600-2. PubMed ID: 17290591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papilloma virus infection and cervical dysplasia.
    Melinte-Popescu A; Costăchescu G
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):853-7. PubMed ID: 23272541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 30 years of colposcopic studies: validity of local destructives treatments.
    Garrido JL
    Eur J Gynaecol Oncol; 2015; 36(3):323-5. PubMed ID: 26189261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conservative management of intraepithelial cervical neoplasia.
    Lickrish GM; Fortier M
    Can Med Assoc J; 1977 Mar; 116(6):641-3. PubMed ID: 608164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal history of papillomavirus-induced dysplasia in the female lower genital tract.
    Vinokurova S; Wentzensen N; Einenkel J; Klaes R; Ziegert C; Melsheimer P; Sartor H; Horn LC; Höckel M; von Knebel Doeberitz M
    J Natl Cancer Inst; 2005 Dec; 97(24):1816-21. PubMed ID: 16368943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus testing and molecular markers of cervical dysplasia and carcinoma.
    Dehn D; Torkko KC; Shroyer KR
    Cancer; 2007 Feb; 111(1):1-14. PubMed ID: 17219448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
    Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
    Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPV-related cervical disease and oropharyngeal cancer.
    Lozza V; Pieralli A; Corioni S; Longinotti M; Bianchi C; Moncini D; Fallani MG
    Arch Gynecol Obstet; 2014 Aug; 290(2):375-9. PubMed ID: 24584479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of human papillomavirus in Mazandaran Province, Islamic Republic of Iran.
    Hamkar R; Azad TM; Mahmoodi M; Seyedirashti S; Severini A; Nategh R
    East Mediterr Health J; 2002 Nov; 8(6):805-11. PubMed ID: 15568458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of HPV 53, HPV 73 and CP8304 in genital epithelial lesions with different grades of dysplasia.
    Meyer T; Arndt R; Beckmann ER; Padberg B; Christophers E; Stockfleth E
    Int J Gynecol Cancer; 2001; 11(3):198-204. PubMed ID: 11437925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal cervical cytology in the teen-ager: a continuing problem.
    Feldman MJ; Linzey EM; Srebnik E; Kent DR; Goldstein AI; Nelson M
    Am J Obstet Gynecol; 1976 Oct; 126(4):418-21. PubMed ID: 984102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and morphologic aspects of cervical papillomavirus infection].
    Kolomiets LA; Urazova LN; Sevost'ianova NV; Churuksaeva ON
    Vopr Onkol; 2002; 48(1):43-6. PubMed ID: 12101564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.